Skip to content

COR

Cencora, Inc.

NYSE · USHealthcareMedical - Distribution
$303.99-1.27%

Price as of Jul 20, 2026

COR growth

Cencora, Inc. growth

Reported trailing growth, forward expectations and three-year compound growth rates.

Trailing growth

Year over year

Revenue
+5.9%
EBITDA
+34.8%
EBIT
+32.0%
EPS
+51.2%
Free cash flow
-56.4%
Operating cash flow
-44.6%

Forward estimates

Revenue
+10.6%
EBITDA
-8.7%
EPS
+45.1%

Three-year CAGR

Revenue
+10.4%
EBITDA
+6.3%
EBIT
+9.9%
Net income
-2.9%
EPS
-0.5%
Free cash flow
+13.3%

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.